Columbus Circle Investors’s GenMark Diagnostics, Inc GNMK Stock Holding History

Columbus Circle Investors’s Portfolio GNMK Stock Details GNMK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-37,324	Closed	-$338K	–	320
2015 Q2	$338K	Buy	+37,324	New	+$376K	﹤0.01%	268
2014 Q2	–	Sell	-103,792	Closed	-$1.03M	–	314
2014 Q1	$1.03M	Buy	103,792 +33,770	+48%	+$420K	0.01%	266
2013 Q4	$931K	Sell	70,022 -4,560	-6%	-$55.4K	0.01%	268
2013 Q3	$905K	Sell	74,582 -84,483	-53%	-$906K	0.01%	279
2013 Q2	$1.65M	Buy	+159,065	New	+$2.19M	0.01%	256

Other funds holding GNMK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

CCM

Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Columbus Circle Investors's GNMK Position: Q3 2015 in Review

Columbus Circle Investors sold out of GenMark Diagnostics, Inc (GNMK) in Q3 2015, closing a stake of 37,324 shares — an estimated $338K sold.

Columbus Circle Investors first reported a position in GNMK in Q2 2013 and held it in 5 quarters. The position peaked at $1.65M in Q2 2013. 88 funds tracked by Wall St. Rank hold GNMK as of Q3 2015.

Columbus Circle Investors reported no remaining GenMark Diagnostics, Inc position as of Q3 2015 after selling out during the quarter.
Columbus Circle Investors sold 37,324 GenMark Diagnostics, Inc shares in Q3 2015, an estimated $338K.
Columbus Circle Investors first reported a position in GenMark Diagnostics, Inc in Q2 2013 and held it in 5 quarters.
Columbus Circle Investors's GenMark Diagnostics, Inc position peaked at $1.65M in Q2 2013.
88 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q3 2015.

Based on Columbus Circle Investors's 13F filing for Q3 2015, filed 2 Nov 2015.